Wynzora is a Topical Cream in the Human Prescription Drug category. It is labeled and distributed by Mc2 Therapeutics Ltd. The primary component is Calcipotriene; Betamethasone Dipropionate.
| Product ID | 73499-001_252abab8-2793-46c6-9af0-7a88ecf41a36 |
| NDC | 73499-001 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Wynzora |
| Generic Name | Calcipotriene And Betamethasone Dipropionate |
| Dosage Form | Cream |
| Route of Administration | TOPICAL |
| Marketing Start Date | 2021-06-30 |
| Marketing Category | NDA / |
| Application Number | NDA213422 |
| Labeler Name | MC2 Therapeutics Ltd |
| Substance Name | CALCIPOTRIENE; BETAMETHASONE DIPROPIONATE |
| Active Ingredient Strength | 50 ug/g; mg/g |
| Pharm Classes | Vitamin D [CS],Vitamin D Analog [EPC],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2021-06-30 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 73499-001 | Wynzora | Calcipotriene and Betamethasone dipropionate |
| 0781-7165 | CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE | calcipotriene and betamethasone dipropionate |
| 45802-889 | calcipotriene and betamethasone dipropionate | calcipotriene and betamethasone dipropionate |
| 45802-989 | Calcipotriene and Betamethasone Dipropionate | calcipotriene and betamethasone dipropionate |
| 51672-1402 | Calcipotriene and Betamethasone Dipropionate | Calcipotriene and Betamethasone Dipropionate |
| 63629-8618 | calcipotriene and betamethasone dipropionate | calcipotriene and betamethasone dipropionate |
| 63629-8619 | calcipotriene and betamethasone dipropionate | calcipotriene and betamethasone dipropionate |
| 63646-040 | calcipotriene and betamethasone dipropionate | calcipotriene and betamethasone dipropionate |
| 66993-937 | Calcipotriene and Betamethasone Dipropionate | Calcipotriene and Betamethasone Dipropionate |
| 66993-938 | Calcipotriene and Betamethasone Dipropionate | Calcipotriene and Betamethasone Dipropionate |
| 50222-302 | ENSTILAR | calcipotriene and betamethasone dipropionate |
| 50222-227 | Taclonex | calcipotriene and betamethasone dipropionate |
| 50222-501 | TACLONEX | calcipotriene and betamethasone dipropionate |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() WYNZORA 79258125 not registered Live/Pending |
Horten Advokatpartnerselskab 2019-02-26 |